No actionable signal from this insider cluster. The sales are trivial in size and consistent with option exercise and tax planning. Monitor for any upcoming corporate events (earnings, pipeline updates) that could provide context, but this filing alone does not warrant a trading response.
CYTK drugs
CYTK drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 2 $71.93entry
- T+1 · 3mo ago +2.81%α +1.76% · $73.95
- T+5 · 2mo ago +2.35%α +3.31% · $73.62
- T+20 · 7w ago −8.77%α −8.62% · $65.62
- T+52 · todayOpen
- T+60 · in 10d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three CYTK insiders (CEO, EVP, Director) sold a total of $1.59M in open-market shares over a 7-day window, primarily from option exercises and same-day sales. The total represents just 0.016% of the $9.9B market cap, making this a routine, non-informative cluster with no material signal for the stock.
Key Financial Metrics
Key Facts
- Total open-market insider sales: $1.59M (0.016% of $9.9B market cap)
- CEO Blum sold 7,500 shares at $70.24 after exercising options at $10.60
- EVP Callos sold 10,000 shares at $70.24 after exercising options at $0 and $23.26
- Director Parshall sold 5,000 shares at $71.48 with no accompanying derivative exercise
- All sales are small relative to company size and consistent with routine option-exercise liquidity
Financial Impact
Insider sales of $1.59M represent 0.016% of market cap, negligible economic impact
Risk Factors
- Insider sales, while small, could be followed by larger sales if the stock appreciates further
- No material risk identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CYTK-1788332530884 |
Track record
46 reports on CYTK
7 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +8.59% at T+20 after the Sep 15, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $53.76 Now $56.13 +4.41% settles Dec 15
- Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.13 Now $56.13 +0.00% settles Dec 14
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $56.18 Now $56.13 −0.09% settles Dec 9
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $56.18 Now $56.13 −0.09% settles Dec 9
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $55.14 Now $56.13 +1.80% settles Dec 8
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $55.14 Now $56.13 +1.80% settles Dec 8
- Nov 4, 202612d ago 8-K Bullish 6/10 No price data
- Nov 4, 202612d ago Press Release Neutral 5/10 Entry $55.55 Now $56.13 +1.04% settles Dec 4
- Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $63.60 Now $56.13 −11.75% settles Dec 3
- Nov 2, 202614d ago Press Release Neutral 3/10 Entry $62.03 Now $56.13 −9.51% settles Dec 1
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers